| Advancing Wellbeing
Through Human + AI

| Advancing Wellbeing
Through Human + AI

Experience a new era in healthcare where precision and efficiency converge to redefine early detection and timely interventions. Join us in the pursuit of better health, improved outcomes, and a brighter future by scheduling a demo today.

Nsight360 uses deep-learning AI

| Nsight360: Saving Sight

360 Intelligent Diagnostics makes it easy, efficient, and affordable to identify the risk of diabetic retinopathy. With Nsight360, the first product in our Ophthalytics product line, comprehensive reports from retinal scans are generated in minutes. The diagnostic images come from easily accessible and readily available cameras.

On any given day, millions of cases are progressing undiagnosed, as the threats of diabetes grow rapidly around the world. Nsight360 answers this notorious care gap – especially among the underserved – with such efficiency, effectiveness, and affordability that the best way to describe it is to demonstrate it.

| What Makes Nsight360 Unique?

AI-Powered Precision

Our deep-learning AI technology ensures the fastest and most accurate assessments for diabetic retinopathy and are based on existing clinical practice guidelines.

Camera Agnostic

Nsight360 works seamlessly with any camera, both stationary and portable, offering point-of-care evaluations from 30-degree to 200-degree fields of view.

Portable & Easy to Deploy

Because our technology integrates with hand-held cameras, assessments can be conducted anywhere by anyone, even a home health aide in a rural patient’s home.

95% compliance rate

| Unlock a 95% diabetic eye exam compliance rate in just 1 year.

Introducing a complete solution with the Optomed Aurora FDA-approved handheld fundus camera. This a game-changing opportunity for providers to maximize ROI.

| Pioneering Research

A Prospective Study on Diabetic Retinopathy Detection Based on Modify Convolutional Neural Network Using Fundus Images at Sindh Institute of Ophthalmology & Visual Sciences

Read the peer-reviewed journal article authored by our founders.

| We’re on a Mission
to Advance Healthcare

Our mission is rooted in harnessing deep-learning AI to advance health equity by providing life-changing care to underserved communities. Although we are starting with diabetic retinopathy – and Nsight360 – we are already working on AI applications that will provide early diagnosis for a host of other diseases.

| We’re on a Mission
to Advance Healthcare

Our mission is rooted in harnessing deep-learning AI to advance health equity by providing life-changing care to underserved communities. Although we are starting with diabetic retinopathy – and Nsight360 – we are already working on AI applications that will provide early diagnosis for a host of other diseases.